Levine Cancer Institute is a clinical research site located in Charlotte, North Carolina, United States 28204.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
Levine Cancer Institute has participated in 289 clinical trials with 126 currently active.
Therapeutic areas: Multiple Myeloma, Pancreas Adenocarcinoma, Cachexia.
Sponsors: SkylineDx, Wake Forest University Health Sciences, Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Charlotte
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Levine Cancer Institute has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Levine Cancer Institute has 289 clinical trials on record, with 126 currently active. Their work covers Multiple Myeloma, Pancreas Adenocarcinoma, Cachexia.
Levine Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.